Tumour stem cells in bone

Mone Zaidi () and Simón Méndez-Ferrer ()
Additional contact information
Mone Zaidi: Mone Zaidi and Simón Méndez-Ferrer are in the Mount Sinai Bone Program, Icahn School of Medicine at Mount Sinai, New York, New York 10029, USA.
Simón Méndez-Ferrer: Mone Zaidi and Simón Méndez-Ferrer are in the Mount Sinai Bone Program, Icahn School of Medicine at Mount Sinai, New York, New York 10029, USA.

Nature, 2013, vol. 499, issue 7459, 414-416

Abstract: Activation of the signalling molecule SHP2 is implicated in driving several cancers. In a newly described class of bone-progenitor cells, however, it seems that the protein acts as a tumour suppressor. See Letter p.491

Date: 2013
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/nature12412 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:499:y:2013:i:7459:d:10.1038_nature12412

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/nature12412

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().